LCM
ABBV icon

Liberty Capital Management’s AbbVie ABBV Stock Holding History

Liberty Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
+42,332
New +$9.11M 1.83% 11
2025
Q4 		$9.59M Buy
41,980
+133
+0.3% +$30.3K 1.79% 13
2025
Q3 		$9.69M Buy
41,847
+582
+1% +$119K 1.82% 12
2025
Q2 		$7.66M Buy
41,265
+2,079
+5% +$386K 1.55% 16
2025
Q1 		$8.21M Sell
39,186
-65
-0.2% -$12.6K 1.83% 16
2024
Q4 		$6.97M Buy
39,251
+103
+0.3% +$18.9K 1.55% 18
2024
Q3 		$7.73M Sell
39,148
-16
-0% -$2.99K 1.71% 18
2024
Q2 		$6.72M Buy
39,164
+1,806
+5% +$299K 1.59% 18
2024
Q1 		$6.8M Sell
37,358
-429
-1% -$73.9K 1.68% 18
2023
Q4 		$5.86M Buy
37,787
+940
+3% +$137K 1.54% 19
2023
Q3 		$5.49M Buy
36,847
+4,025
+12% +$591K 1.62% 19
2023
Q2 		$4.42M Buy
32,822
+932
+3% +$137K 1.33% 24
2023
Q1 		$5.08M Sell
31,890
-212
-0.7% -$32.4K 1.67% 18
2022
Q4 		$5.19M Buy
32,102
+453
+1% +$69.5K 1.8% 17
2022
Q3 		$4.25M Buy
31,649
+46
+0.1% +$6.6K 1.59% 19
2022
Q2 		$4.84M Sell
31,603
-760
-2% -$116K 1.72% 18
2022
Q1 		$5.25M Buy
32,363
+1,707
+6% +$248K 1.53% 20
2021
Q4 		$4.15M Sell
30,656
-1,793
-6% -$212K 1.12% 30
2021
Q3 		$3.5M Buy
32,449
+10
+0% +$1.14K 1.03% 33
2021
Q2 		$3.65M Sell
32,439
-513
-2% -$57.8K 1.11% 30
2021
Q1 		$3.57M Buy
32,952
+2,485
+8% +$266K 1.23% 26
2020
Q4 		$3.27M Buy
+30,467
New +$2.93M 1.18% 27
2020
Q2 		$2.84M Sell
28,897
-107
-0.4% -$9.42K 1.23% 27
2020
Q1 		$2.21M Buy
29,004
+770
+3% +$65.6K 1.15% 32
2019
Q4 		$2.5M Buy
28,234
+50
+0.2% +$4.15K 1.03% 36
2019
Q3 		$2.13M Buy
28,184
+92
+0.3% +$6.31K 0.94% 38
2019
Q2 		$2.04M Sell
28,092
-121
-0.4% -$9.51K 0.92% 39
2019
Q1 		$2.27M Sell
28,213
-231
-0.8% -$18.9K 1.15% 35
2018
Q4 		$2.62M Sell
28,444
-644
-2% -$56.6K 1.61% 26
2018
Q3 		$2.75M Buy
29,088
+486
+2% +$46.1K 1.44% 30
2018
Q2 		$2.65M Buy
28,602
+388
+1% +$37.9K 1.55% 28
2018
Q1 		$2.67M Buy
28,214
+108
+0.4% +$11.9K 1.61% 27
2017
Q4 		$2.82M Sell
28,106
-550
-2% -$51.8K 1.49% 26
2017
Q3 		$2.75M Buy
28,656
+875
+3% +$66.6K 1.51% 27
2017
Q2 		$2M Sell
27,781
-2,105
-7% -$142K 1.21% 32
2017
Q1 		$1.95M Buy
29,886
+1,655
+6% +$104K 1.17% 35
2016
Q4 		$1.74M Buy
28,231
+35
+0.1% +$2.14K 1.13% 37
2016
Q3 		$1.78M Buy
28,196
+315
+1% +$20.4K 1.16% 34
2016
Q2 		$1.73M Buy
27,881
+1,411
+5% +$86K 1.17% 35
2016
Q1 		$1.51M Buy
26,470
+1,050
+4% +$58.5K 1.13% 38
2015
Q4 		$1.51M Sell
25,420
-550
-2% -$31.7K 1.14% 36
2015
Q3 		$1.41M Buy
25,970
+30
+0.1% +$1.95K 1.11% 38
2015
Q2 		$1.74M Buy
25,940
+120
+0.5% +$7.83K 1.17% 39
2015
Q1 		$1.51M Hold
25,820
– – 1.01% 44
2014
Q4 		$1.69M Sell
25,820
-620
-2% -$39.1K 1.17% 34
2014
Q3 		$1.53M Sell
26,440
-314
-1% -$17.4K 1.11% 37
2014
Q2 		$1.51M Sell
26,754
-1,392
-5% -$73K 1.07% 40
2014
Q1 		$1.45M Sell
28,146
-2,890
-9% -$146K 1.06% 41
2013
Q4 		$1.64M Sell
31,036
-200
-0.6% -$9.83K 1.17% 36
2013
Q3 		$1.4M Buy
31,236
+2,175
+7% +$96.4K 1.11% 36
2013
Q2 		$1.2M Buy
+29,061
New +$1.27M 1.03% 39

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Liberty Capital Management's ABBV Position: Q2 2026 in Review

Liberty Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 42,332 shares worth $10.7M. The stake represents 1.83% of the portfolio and ranks #11 among its holdings. This is a return to the name: Liberty Capital Management previously reported a position in ABBV as recently as Q4 2025.

Liberty Capital Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Liberty Capital Management held 42,332 shares of AbbVie worth $10.7M as of Q2 2026.
  • AbbVie was a new Liberty Capital Management position in Q2 2026.
  • AbbVie made up 1.83% of Liberty Capital Management's portfolio in Q2 2026, its #11 holding.
  • Liberty Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Liberty Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.